Stemson is going to use minipigs in the next stage of their hair cloning research

[It_is_over_for_nw7]

As far as surgical hair transplantation is concerned, I think the limitation of blood flow and trauma, even if minimal, will always apply, so more sessions will have to be done if you want densities similar or equal to the natural one. I thought that with the use of robots instead of human hands a lot could have been solved, but apparently as far as hair transplantation is concerned, robots give a lower result than the surgeon for now. I too think it's better to get your hair back now rather than at an older age when the priorities are different, in fact we often speak "only" of an aesthetic problem, as if good sociability and high self-esteem count for nothing for human beings. My superior in the military always said that human beings only need three things: food, sleep, poop. I would also add another two which are leisure and sociality which also includes sexuality, without these a normal person lives badly and ends up going crazy. Not to mention that being forced to not be able to open up to the fullest, not to have the look you want is a limitation to the individual's self-determination and makes the person feel old before their time. Not to mention when this pathology arises at a young age such as adolescence, the boy will end up feeling finished and out of place, and let's be honest, it's not that his other peers are kind and mature with him, he will always end up being the one targeted for some joke, he will always have to be mature and not take it out on something that ultimately ruined his life and denied him a healthy relationship with the opposite sex. I find it really hateful and petty to call it only an aesthetic problem when a person's appearance is important (let's not say otherwise) and that this affects a person's character and future relationships.

 

[Armando Jose]

You do not know the illusion that these were the results of Stemson

 

[Joxy]

Kevin D’Amour, PhD, Joins Stemson Therapeutics as Chief Scientific Officer​

Pioneering cell therapy leader will direct Stemson’s efforts to develop the first iPSC-derived cell therapy to treat hair loss

Kevin D’Amour, PhD, Joins Stemson Therapeutics as Chief Scientific Officer

Stemson Therapeutics, a private biotechnology company developing an iPSC-derived autologous cell therapy to regenerate healthy hair follicles, announc

www.businesswire.com

 

[Joxy]

 

[Armando Jose]

A lot of luck

 

[Raccooner]

Why don't they stop talking or lecturing to audiences and start DOING SOMETHING to test human subjects! I don't expect them to get off home base the way they do things. All they do is talk, bury their failures and do nothing. They're worse than politicians. They at least do things, mostly bad. It's a good thing Stemson doesn't have publicly traded stock because by now it would be worthless at this point. People want to see progress, not be given questionable promises. They've been a company since 2018 and have produced nothing so far for public benefit. Great job!

 

[werefckd]

Kevin D’Amour, PhD, Joins Stemson Therapeutics as Chief Scientific Officer​

Kevin D’Amour, PhD, Joins Stemson Therapeutics as Chief Scientific Officer

SAN DIEGO, February 01, 2023--Stemson Therapeutics, a private biotechnology company developing an iPSC-derived autologous cell therapy to regenerate healthy hair follicles, announced today that Kevin D’Amour, a veteran cell therapy development expert, has joined Stemson as Chief Scientific...

finance.yahoo.com

Kevin D’Amour, PhD, was at ViaCyte from 2002 until 2021 and served as the company’s Chief Scientific Officer from 2011 – 2021. At ViaCyte, he led the development of the first stem cell-derived cell therapies designed to replace pancreatic beta cells for the treatment of type 1 diabetes. Under Kevin’s leadership, ViaCyte took three cell therapy products into the clinic. ViaCyte was acquired by Vertex in 2022.

 

[badnewsbearer]

this guy also literally appeared in a movie called "the human trial"

THE HUMAN TRIAL

Opens in select theaters June 2022. Behind every breakthrough are the patients who risk everything for everybody else. Would you go first?

www.thehumantrial.com

maybe this means they are getting serious about clinical studies, lets hope this is what it means

 

[badnewsbearer]

"In addition to leading research advances in the stem cell program,

*Dr. D’Amour is frequently called upon to address the biological aspects of ViaCyte’s technology platform with regulating bodies, such as the US patent office and the FDA*.



hiring this guy must mean they are at least planning for a clinical study at some point in the near future

 

[cryingariver]

When will this be available?

 

[Armando Jose]

When will this be available?

Domani or post domani

 

[Raccooner]

All Stemson does is hire people who are basically not getting the job done. They cover up their failures with silence. They should be ashamed of themselves.

 

[badnewsbearer]

All Stemson does is hire people who are basically not getting the job done. They cover up their failures with silence. They should be ashamed of themselves.

wtf is this comment. what is your actual argument?

 

[Raccooner]

wtf is this comment. what is your actual argument?

My argument is they tell us nothing that they've accomplished. Their biggest accomplishment is hiring people to their company. What in their 5 year history have they done other than grow a few pathetic human transplanted hairs onto a mouse model? They've been in early pre-clinical stages forever and I think they're going nowhere fast! Every time CEO Geoff Hamilton talks it seems he is avoidant and nervous like he himself doesn't seem convinced Stemson will be having a cure for us anytime in the foreseeable future. I really hate how this company doesn't admit failure. They just shamelessly keep us in limbo. They don't invite questions from the public. They have no media or public relations to speak of if anyone has an inquiry. No telephone number is listed on their site, no emails get returned anymore. Last time I got a reply was in Summer, 2020 from them. The company is run like they don't give a hoot about the public and are afraid of telling how bad things are and losing their gravy train. This post dates back to early 2021 that Stemson will be testing on mini pigs. And how did that go? Does anyone know? Seems no news is bad news. They need new management there, and lots of the administration needs to be replaced with people who are willing to talk to the public, not just speak briefly at conventions. And yet they are hiring again! Someone to test on mice. What progress is being made there. Can you tell me please? All they do is hire people who accomplish diddly. Imagine if they had public stock, it would be worthless!

 

[badnewsbearer]

My argument is they tell us nothing that they've accomplished. Their biggest accomplishment is hiring people to their company. What in their 5 year history have they done other than grow a few pathetic human transplanted hairs onto a mouse model? They've been in early pre-clinical stages forever and I think they're going nowhere fast! Every time CEO Geoff Hamilton talks it seems he is avoidant and nervous like he himself doesn't seem convinced Stemson will be having a cure for us anytime in the foreseeable future. I really hate how this company doesn't admit failure. They just shamelessly keep us in limbo. They don't invite questions from the public. They have no media or public relations to speak of if anyone has an inquiry. No telephone number is listed on their site, no emails get returned anymore. Last time I got a reply was in Summer, 2020 from them. The company is run like they don't give a hoot about the public and are afraid of telling how bad things are and losing their gravy train. This post dates back to early 2021 that Stemson will be testing on mini pigs. And how did that go? Does anyone know? Seems no news is bad news. They need new management there, and lots of the administration needs to be replaced with people who are willing to talk to the public, not just speak briefly at conventions. And yet they are hiring again! Someone to test on mice. What progress is being made there. Can you tell me please? All they do is hire people who accomplish diddly. Imagine if they had public stock, it would be worthless!

why do YOU think they owe you that? im sure they report enough to their investors to keep them interested additionally I am sure they are making progress otherwise they woultn have hired someone who is associated with clinical studies. if they are testing on pigs and there isn't a major breakthrough why would they publish that? some things might be proprietary as well as now its not just a research institute but a company with actual investor backing.

>The company is run like they don't give a hoot about the public

what company would give a sh*t about some random bald guy on a forum asking them questions over mail or the phone? like thats not a very common occurrence in other areas of science I would imagine.

 

[Gump]

wtf is this comment. what is your actual argument?

This guy is crazy. No reputable pharma company releases details about everything they do. In fact, it's suspicious when one does because it looks like they need funding when you see paid announcements about minor progress across several platforms. The fact is that Stemson has a lot of funding (more than any other hairloss company has) and seems to have a legit team. They aren't going to announce anything that isn't substantial, and really don't owe the public anything. Raccooner wants weekly updates when in reality it will likely be a decade before they could bring something to market. Even that might be optimistic.

 

[Baldingtooyoung]

My argument is they tell us nothing that they've accomplished. Their biggest accomplishment is hiring people to their company. What in their 5 year history have they done other than grow a few pathetic human transplanted hairs onto a mouse model? They've been in early pre-clinical stages forever and I think they're going nowhere fast! Every time CEO Geoff Hamilton talks it seems he is avoidant and nervous like he himself doesn't seem convinced Stemson will be having a cure for us anytime in the foreseeable future. I really hate how this company doesn't admit failure. They just shamelessly keep us in limbo. They don't invite questions from the public. They have no media or public relations to speak of if anyone has an inquiry. No telephone number is listed on their site, no emails get returned anymore. Last time I got a reply was in Summer, 2020 from them. The company is run like they don't give a hoot about the public and are afraid of telling how bad things are and losing their gravy train. This post dates back to early 2021 that Stemson will be testing on mini pigs. And how did that go? Does anyone know? Seems no news is bad news. They need new management there, and lots of the administration needs to be replaced with people who are willing to talk to the public, not just speak briefly at conventions. And yet they are hiring again! Someone to test on mice. What progress is being made there. Can you tell me please? All they do is hire people who accomplish diddly. Imagine if they had public stock, it would be worthless!

You're legit delusional bro lol damn.

 

[It_is_over_for_nw7]

This guy is crazy. No reputable pharma company releases details about everything they do. In fact, it's suspicious when one does because it looks like they need funding when you see paid announcements about minor progress across several platforms. The fact is that Stemson has a lot of funding (more than any other hairloss company has) and seems to have a legit team. They aren't going to announce anything that isn't substantial, and really don't owe the public anything. Raccooner wants weekly updates when in reality it will likely be a decade before they could bring something to market. Even that might be optimistic.

This is cope.

I have 0 faith that they will make it work. It sounds too complicated and it won't lead to results.

It's just another "hair cloning" - like idea. Will fail like the rest of them.

 

[badnewsbearer]

This is cope.

I have 0 faith that they will make it work. It sounds too complicated and it won't lead to results.

It's just another "hair cloning" - like idea. Will fail like the rest of them.

do you have any scientific argument besides low IQ incel jargon and "it sounds too complicated"? do you have a PhD in biotechnology or molecular biology? if not how can a total rando like you judge what is complicated and what isn't? I think they are well aware of how complicated this is as they have stressed this 100 times in various interview.

also what the f*** do you mean "just another hair cloning like idea"? of course it is lol. what do you even mean. this approach has never been done and it solves a lot of problems like poor maintenance of inductive capabilities of DP cells in culture, expensive and non scaleable DP culturing process and many more. but I am sure you know very little about what exactly they are doing. your username is also pure cringe

 

[badnewsbearer]

This guy is crazy. No reputable pharma company releases details about everything they do. In fact, it's suspicious when one does because it looks like they need funding when you see paid announcements about minor progress across several platforms. The fact is that Stemson has a lot of funding (more than any other hairloss company has) and seems to have a legit team. They aren't going to announce anything that isn't substantial, and really don't owe the public anything. Raccooner wants weekly updates when in reality it will likely be a decade before they could bring something to market. Even that might be optimistic.

exactly like wtf, we aren't their top investors, they have no obligation to tell us anything and it would be highly uncommon if they did so. imagine approaching a company as a patient of any other condition, you mail biontech of Pfizer about how they should call you to talk about their progress. like, why? I am sure that if they find something for the advancement of the scientific community they will hopefully at least write and publish a paper like they previously did.